Gamida Cell Stock EBITDA
GMDADelisted Stock | USD 1.40 0.09 6.04% |
Gamida Cell fundamentals help investors to digest information that contributes to Gamida Cell's financial success or failures. It also enables traders to predict the movement of Gamida Stock. The fundamental analysis module provides a way to measure Gamida Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gamida Cell stock.
Gamida |
Gamida Cell Company EBITDA Analysis
Gamida Cell's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Gamida Cell EBITDA | (70.62 M) |
Most of Gamida Cell's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gamida Cell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Gamida Cell reported earnings before interest,tax, depreciation and amortization of (70.62 Million). This is 108.05% lower than that of the Biotechnology sector and 170.51% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.81% higher than that of the company.
Gamida EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gamida Cell's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics of similar companies.Gamida Cell is currently under evaluation in ebitda category among its peers.
Gamida Fundamentals
Return On Equity | -11.04 | |||
Return On Asset | -0.41 | |||
Operating Margin | (26.80) % | |||
Current Valuation | 70.28 M | |||
Shares Outstanding | 132.64 M | |||
Shares Owned By Insiders | 11.57 % | |||
Shares Owned By Institutions | 26.48 % | |||
Number Of Shares Shorted | 10.96 M | |||
Price To Earning | (3.97) X | |||
Price To Book | 117.40 X | |||
Price To Sales | 6.44 X | |||
Revenue | 1.78 M | |||
EBITDA | (70.62 M) | |||
Net Income | (63 M) | |||
Cash And Equivalents | 55.06 M | |||
Cash Per Share | 0.92 X | |||
Total Debt | 82.94 M | |||
Current Ratio | 2.57 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (79.12 M) | |||
Short Ratio | 3.51 X | |||
Earnings Per Share | (0.82) X | |||
Target Price | 4.0 | |||
Number Of Employees | 143 | |||
Beta | 1.03 | |||
Market Capitalization | 4.34 M | |||
Total Asset | 102.19 M | |||
Retained Earnings | (479.83 M) | |||
Working Capital | 29.34 M | |||
Current Asset | 56.03 M | |||
Current Liabilities | 9.55 M | |||
Net Asset | 102.19 M |
About Gamida Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gamida Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gamida Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gamida Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Gamida Stock
If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |